FierceBiotechOriginal article
{"a":[{"_":"Roche nabs expanded FDA approval for diagnostic tied to Jazz’s cancer drug","$":{"href":"/medtech/roches-nabs-expanded-fda-approval-diagnostic-aimed-jazzs-cancer-drug","hreflang":"en"}}]}
RegulatoryapprovedZiiheraPositive
AI Analysis
Summary
Roche received expanded FDA clearance for diagnostic tests that identify patients eligible to use Jazz Pharmaceuticals' cancer drug Ziihera, supporting patient selection and treatment optimization.
Outcome Details
FDA granted expanded clearance for Roche's diagnostic tests to identify patients eligible for Jazz Pharmaceuticals' cancer drug Ziihera
Importance:6/10
Sentiment:
0.60
FDA approvaldiagnosticcompanion diagnosticoncologyregulatory clearance
Read the original article
Published by FierceBiotech on August 27, 2026 3:22 AM